检索结果 - Grygorii Ursol
- Showing 1 - 4 results of 4
-
1
Patient-reported outcomes with durvalumab, with or without tremelimumab, plus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer (POSEIDON) 由 Edward B. Garon, Byoung Chul Cho, Alexander Luft, Jorge Alatorre-Alexander, Sarayut Lucien Geater, Sang‐We Kim, Grygorii Ursol, Maen Hussein, Farah Louise Lim, Cheng‐Ta Yang, Luiz H. Araujo, Haruhiro Saito, Niels Reinmuth, Nenad Medić, Helen Mann, Xiaojin Shi, Solange Peters, Tony Mok, Melissa L. Johnson
出版 2023Artigo -
2
Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non–Small-Cell Lung Cancer: The Phase III POSEIDON Study 由 Melissa L. Johnson, Byoung Chul Cho, Alexander Luft, Jorge Alatorre-Alexander, Sarayut Lucien Geater, К. К. Лактионов, Sang‐We Kim, Grygorii Ursol, Maen Hussein, Farah Louise Lim, Cheng‐Ta Yang, Luiz H. Araujo, Haruhiro Saito, Niels Reinmuth, Xiaojin Shi, Lynne Poole, Solange Peters, Edward B. Garon, Tony Mok
出版 2022Artigo -
3
A Brief Report of Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: Outcomes by Tumor PD-L1... 由 Edward B. Garon, Byoung Chul Cho, Alexander Luft, Jorge Alatorre-Alexander, Sarayut Lucien Geater, Dmytro Trukhin, Sang‐We Kim, Grygorii Ursol, Maen Hussein, Farah Louise Lim, Cheng‐Ta Yang, Luiz H. Araujo, Haruhiro Saito, Niels Reinmuth, Milena Kohlmann, Caitlin D. Lowery, Helen Mann, Solange Peters, Tony Mok, Melissa L. Johnson
出版 2024Artigo -
4
Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Stud... 由 Dmytro Trukhin, Elena Poddubskaya, Zoran Andrić, Tamta Makharadze, Ravi Shankar Bellala, Chaiyut Charoentum, Eduardo Patricio Yanez Ruiz, Andrea Fülöp, Irfhan Ali Hyder Ali, Kostas Syrigos, Nuran Katgı, Yamil Alonso Lopez Chuken, Ilieva Rumyana, Jasmin Reyes-Igama, Rita de Cássia Costamilan, Ana Del Campo García, Amalia Florez, Alexandra Paravisini, Susana Millán, Luiz H. Araujo, Carla Maria de Oliveira Ferreira, Hélio Pinczowski, Maria Marcela Fernandes Monteiro, Assen Dudov, Janeta Syrova, Francisco Javier Orlandi Jorquera, Carlos Eduardo Gallardo Arenada, Christian Lorenzo Caglevic Medina, Davit Giorgadze, Nino Mchedlidze, Vladimer Kuchava, Tamar Melkadze, Amiran Matitashvili, Nana Chikhladze, E Samantas, Theodoros Kontakiotis, Beatrix Bálint, Balazs Medgyasszay, Eszter Csánky, Shailesh Bondarde, Lovenish Goyal, Ajay Sharma, Baijumon Balan, Prabrajya Narayan Mohapatra, Kaushalkumar Babubhai Patel, Sachin Sharadchandra Hingmire, Mithun Satish Shah, Kartikeya Jain, Ashish Agrawal, Prashant Kumbhaj, Asis Mukhopadhyay, Paul Khoueiry, Suhana Yusak, Yong Kek Pang, V. Pei Jye, Prathepamalar Yehgambaram, Fuad Ismail, Gokula Kumar Appalanaido, Feliciano Barrón, Ma. Noemi Uy, Felycette Gay Martinez-Lapus, Maria Belen Tamayo, Jennifer Sandoval-Tan, Jamela Anne Osorio Sanchez, Christina G. Galvez, Josephine Contreras-Tolentino, Evgeny Ledin, Daniil Stroyakovskiy, I. V. Kudryavtsev, Vladimir Vladimirov, Evgeniy Gotovkin, М. В. Шомова, Guzel Mukhametshina, Igor Lifirenko, Nina Karaseva, M. Nechaeva, Anna V. Tarasova, Alexander Luft, Lyudmila Kuzina, Marina Petrović, Milan Rančić, Borjan Zaric, Manoch Buranachokphaisan, Sarayut Lucien Geater, Ekkapong Tharavichitkul, Mahmut Gümüş, Igor Bondarenko, Yaroslav Shparyk, Serhii Shevnia, Iryna Lytvyn, Oleksii Kolesnik, Yevhen Hotko, Ivan Sinielnikov, Hryhoriy Adamchuk, Grygorii Ursol, О. І. Іващук, Yuriy Ostapenko, Tetiana Popovska
出版 2021Artigo
相关主题
Chemotherapy
Internal medicine
Lung cancer
Medicine
Oncology
Cancer
Confidence interval
Durvalumab
Hazard ratio
Immunotherapy
Ipilimumab
Tremelimumab
Cisplatin
Environmental health
Gastroenterology
Pembrolizumab
Population
Bevacizumab
Biosimilar
Carboplatin
Chemoradiotherapy
Clinical endpoint
Nausea
Nivolumab
Pemetrexed
Randomized controlled trial
Regimen
Surgery